30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Constellation Pharmaceuticals Inc (CNST)

Track

The most recent insider trading activity occurred on February 22, 2021. This involved a planned sale of 6,260 shares by Chief Financial Officer Emma Reeve. Prior to this, other planned sales by Ms. Reeve and sales by COLUMN GROUP L P were noted in February 2021. Earlier transactions in January and December 2020 also consisted of planned sales.
Stock chart
Ticker: CNST Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Reeve Emma
Chief Financial Officer
1 sale — total 235,373 USD
Planned sale 22 Feb 2021
Value US$4,024,204.02 | Price 477.23 | Shares 21,166
Planned sale 19 Feb 2021
Value US$4,563,092.67 | Price 338.99 | Shares 39,714
Planned sale 18 Feb 2021
Value US$41,343.06 | Price 37.58 | Shares 1,100
Planned sale 17 Feb 2021
Value US$15,397.84 | Price 37.56 | Shares 410
Sale 17 Feb 2021
Value US$369,503.00 | Price 36.95 | Shares 10,000
Sale 17 Feb 2021
Value US$369,503.00 | Price 36.95 | Shares 10,000
Planned sale 19 Jan 2021
Value US$252,888.69 | Price 35.11 | Shares 7,203
Planned sale 19 Jan 2021
Value US$41,342.05 | Price 33.69 | Shares 1,227
Planned sale 19 Jan 2021
Value US$290,231.90 | Price 33.08 | Shares 8,773
Planned sale 21 Dec 2020
Value US$140,769.14 | Price 35.02 | Shares 4,020
Planned sale 21 Dec 2020
Value US$200,805.18 | Price 35.11 | Shares 5,720
Planned sale 8 Jun 2020
Value US$8,936.46 | Price 38.35 | Shares 233
Planned sale 8 Jun 2020
Value US$5,423.88 | Price 37.67 | Shares 144
Planned sale 8 Jun 2020
Value US$7,757.23 | Price 36.59 | Shares 212
Planned sale 12 May 2020
Value US$461,981.46 | Price 50.17 | Shares 9,209
Planned sale 12 May 2020
Value US$469,488.41 | Price 50.18 | Shares 9,357
Planned sale 12 May 2020
Value US$211,474.35 | Price 50.05 | Shares 4,225
Planned sale 12 May 2020
Value US$305,621.59 | Price 50.10 | Shares 6,100
Planned sale 11 May 2020
Value US$1,300.00 | Price 50.00 | Shares 26
Planned sale 11 May 2020
Value US$5,000.00 | Price 50.00 | Shares 100
Planned sale 11 May 2020
Value US$795,623.14 | Price 49.53 | Shares 16,062
Planned sale 8 May 2020
Value US$631,055.36 | Price 49.53 | Shares 12,741
Planned sale 6 May 2020
Value US$503,896.60 | Price 40.10 | Shares 12,566
Planned sale 6 May 2020
Value US$338,599.50 | Price 45.15 | Shares 7,500
Planned sale 6 May 2020
Value US$516,544.56 | Price 45.06 | Shares 11,463
Planned sale 6 May 2020
Value US$451,553.00 | Price 45.16 | Shares 10,000
Planned sale 5 May 2020
Value US$189,817.40 | Price 40.01 | Shares 4,744
Planned sale 5 May 2020
Value US$125,823.90 | Price 40.01 | Shares 3,145
Planned sale 27 Apr 2020
Value US$16,052.00 | Price 40.13 | Shares 400
Planned sale 27 Apr 2020
Value US$16,049.00 | Price 40.12 | Shares 400
Planned sale 20 Apr 2020
Value US$26,550.09 | Price 33.65 | Shares 789
Planned sale 17 Apr 2020
Value US$80,939.30 | Price 35.19 | Shares 2,300
Planned sale 17 Apr 2020
Value US$26,819.64 | Price 35.29 | Shares 760
Planned sale 16 Apr 2020
Value US$35,552.01 | Price 34.09 | Shares 1,043
Planned sale 16 Apr 2020
Value US$65,085.27 | Price 33.29 | Shares 1,955
Planned sale 14 Apr 2020
Value US$43,122.70 | Price 35.20 | Shares 1,225
Planned sale 9 Apr 2020
Value US$20,625.54 | Price 35.02 | Shares 589
Planned sale 9 Apr 2020
Value US$3,886.99 | Price 35.02 | Shares 111
Planned sale 9 Apr 2020
Value US$22,236.24 | Price 35.02 | Shares 635
Buy 20 Mar 2020
Value US$128,227.85 | Price 23.15 | Shares 5,539
Buy 20 Mar 2020
Value US$128,227.85 | Price 23.15 | Shares 5,539
Buy 19 Mar 2020
Value US$808,701.30 | Price 22.38 | Shares 36,135
Buy 19 Mar 2020
Value US$808,701.30 | Price 22.38 | Shares 36,135
Planned sale 9 Mar 2020
Value US$4,279.05 | Price 32.92 | Shares 130
Planned sale 9 Mar 2020
Value US$10,746.30 | Price 32.08 | Shares 335
Planned sale 9 Mar 2020
Value US$4,737.90 | Price 31.17 | Shares 152
Planned sale 13 Feb 2020
Value US$193,539.21 | Price 35.06 | Shares 5,521
Planned sale 13 Feb 2020
Value US$156,858.72 | Price 35.07 | Shares 4,473
Planned sale 12 Feb 2020
Value US$38,623.97 | Price 35.02 | Shares 1,103
Planned sale 12 Feb 2020
Value US$52,527.00 | Price 35.02 | Shares 1,500
Sale 11 Feb 2020
Value US$299,506.50 | Price 35.03 | Shares 8,550
Sale 11 Feb 2020
Value US$50,107.20 | Price 35.04 | Shares 1,430
Sale 11 Feb 2020
Value US$252,708.48 | Price 35.04 | Shares 7,212
Sale 10 Feb 2020
Value US$472,356.96 | Price 33.51 | Shares 14,096
Sale 10 Feb 2020
Value US$7,000.00 | Price 35.00 | Shares 200
Buy 13 Dec 2019
Value US$13,800,000.00 | Price 34.50 | Shares 400,000
Buy 13 Dec 2019
Value US$13,800,000.00 | Price 34.50 | Shares 400,000
Planned sale 6 Nov 2019
Value US$22,389.84 | Price 30.84 | Shares 726
Planned sale 6 Nov 2019
Value US$468,260.28 | Price 29.75 | Shares 15,740
Planned sale 6 Nov 2019
Value US$239,631.38 | Price 20.01 | Shares 11,976
Planned sale 6 Nov 2019
Value US$118,838.68 | Price 19.20 | Shares 6,188
Planned sale 6 Nov 2019
Value US$446,518.26 | Price 18.40 | Shares 24,264
Planned sale 6 Nov 2019
Value US$73,157.93 | Price 17.59 | Shares 4,158
Planned sale 6 Nov 2019
Value US$41,978.85 | Price 16.31 | Shares 2,574
Planned sale 6 Nov 2019
Value US$12,602.48 | Price 36.01 | Shares 350
Planned sale 6 Nov 2019
Value US$711,579.34 | Price 35.23 | Shares 20,200
Planned sale 6 Nov 2019
Value US$378,794.84 | Price 31.32 | Shares 12,095
Planned sale 6 Nov 2019
Value US$875,527.53 | Price 30.19 | Shares 29,005
Planned sale 6 Nov 2019
Value US$514,952.18 | Price 25.06 | Shares 20,550
Planned sale 6 Nov 2019
Value US$67,198.29 | Price 21.20 | Shares 3,170
Planned sale 6 Nov 2019
Value US$350,726.66 | Price 20.18 | Shares 17,380
Planned sale 6 Nov 2019
Value US$143,356.50 | Price 19.11 | Shares 7,500
Planned sale 6 Nov 2019
Value US$195,076.35 | Price 18.58 | Shares 10,500
Planned sale 6 Nov 2019
Value US$78,978.15 | Price 17.55 | Shares 4,500
Planned sale 6 Nov 2019
Value US$191,394.42 | Price 35.11 | Shares 5,451
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2021-02-23 2021-02-22 PlS Planned sale
Reeve Emma

Chief Financial Officer

Officer
21,166 +6.0%
477.23
US$4,024,204 		21,166 +6.0% 477.23 US$4,024,204
2021-02-23 2021-02-19 PlS Planned sale
Reeve Emma

Chief Financial Officer

Officer
39,714 -15.1%
338.99
US$4,563,093 		39,714 -15.1% 338.99 US$4,563,093
2021-02-19 2021-02-18 PlS Planned sale
Reeve Emma

Chief Financial Officer

Officer
56,978 -21.3%
299.11
US$2,044,120 		56,978 -21.3% 299.11 US$2,044,120
2021-02-19 2021-02-17 PlS Planned sale
Reeve Emma

Chief Financial Officer

Officer
410 -100.0%
37.56
US$15,398 		410 -100.0% 37.56 US$15,398
2021-02-19 2021-02-17 S Sale
3.9
COLUMN GROUP L P
Large shareholder
10,000 -9.2%
36.95
US$369,503 		10,000 -9.2% 36.95 US$369,503
2021-02-19 2021-02-17 S Sale
3.9
COLUMN GROUP L P
Large shareholder
10,000 -9.2%
36.95
US$369,503 		10,000 -9.2% 36.95 US$369,503
2021-01-20 2021-01-19 PlS Planned sale
Valentine Karen

See Remarks

Officer
7,203 -100.0%
35.11
US$252,889 		7,203 -100.0% 35.11 US$252,889
2021-01-20 2021-01-19 PlS Planned sale
Valentine Karen

See Remarks

Officer
1,227 -14.6%
33.69
US$41,342 		1,227 -14.6% 33.69 US$41,342
2021-01-20 2021-01-19 PlS Planned sale
Valentine Karen

See Remarks

Officer
8,773 -51.0%
33.08
US$290,232 		8,773 -51.0% 33.08 US$290,232
2020-12-28 2020-12-21 PlS Planned sale
2.4
GOLDSMITH MARK A
Non-Executive Director Large shareholder
4,020 -2.8%
35.02
US$140,769 		4,020 -2.8% 35.02 US$140,769
2020-12-22 2020-12-21 PlS Planned sale
Reeve Emma

Chief Financial Officer

Officer
5,720 -100.0%
35.11
US$200,805 		5,720 -100.0% 35.11 US$200,805
2020-06-10 2020-06-08 PlS Planned sale
Reeve Emma

Chief Financial Officer

Officer
233 -100.0%
38.35
US$8,936 		233 -100.0% 38.35 US$8,936
2020-06-10 2020-06-08 PlS Planned sale
Reeve Emma

Chief Financial Officer

Officer
144 -38.2%
37.67
US$5,424 		144 -38.2% 37.67 US$5,424
2020-06-10 2020-06-08 PlS Planned sale
Reeve Emma

Chief Financial Officer

Officer
212 -36.0%
36.59
US$7,757 		212 -36.0% 36.59 US$7,757
2020-05-13 2020-05-12 PlS Planned sale
Raythatha Jigar

See Remarks

Executive Director
9,209 -38.1%
50.17
US$461,981 		9,209 -38.1% 50.17 US$461,981
2020-05-13 2020-05-12 PlS Planned sale
1.6
Senderowicz Adrian

Chief Medical Officer

Officer
9,357 -37.1%
50.18
US$469,488 		9,357 -37.1% 50.18 US$469,488
2020-05-13 2020-05-12 PlS Planned sale
2.4
GOLDSMITH MARK A
Non-Executive Director Large shareholder
4,225 -2.9%
50.05
US$211,474 		4,225 -2.9% 50.05 US$211,474
2020-05-13 2020-05-12 PlS Planned sale
Audia James E
Non-Executive Director
6,100 -19.3%
50.10
US$305,622 		6,100 -19.3% 50.10 US$305,622
2020-05-13 2020-05-11 PlS Planned sale
Raythatha Jigar

See Remarks

Executive Director
26 -0.2%
50.00
US$1,300 		26 -0.2% 50.00 US$1,300
2020-05-13 2020-05-11 PlS Planned sale
2.4
GOLDSMITH MARK A
Non-Executive Director Large shareholder
100 -0.1%
50.00
US$5,000 		100 -0.1% 50.00 US$5,000
2020-05-12 2020-05-11 PlS Planned sale
Reeve Emma

Chief Financial Officer

Officer
16,062 -100.0%
49.53
US$795,623 		16,062 -100.0% 49.53 US$795,623
2020-05-12 2020-05-08 PlS Planned sale
Reeve Emma

Chief Financial Officer

Officer
12,741 -100.0%
49.53
US$631,055 		12,741 -100.0% 49.53 US$631,055
2020-05-07 2020-05-06 PlS Planned sale
Valentine Karen

See Remarks
12,566 -100.0%
40.10
US$503,897 		12,566 -100.0% 40.10 US$503,897
2020-05-07 2020-05-06 PlS Planned sale
Audia James E
7,500 -19.2%
45.15
US$338,600 		7,500 -19.2% 45.15 US$338,600
2020-05-07 2020-05-06 PlS Planned sale
2.4
GOLDSMITH MARK A
11,463 -7.4%
45.06
US$516,545 		11,463 -7.4% 45.06 US$516,545
2020-05-07 2020-05-06 PlS Planned sale
Trojer Patrick

Chief Scientific Officer
10,000 -100.0%
45.16
US$451,553 		10,000 -100.0% 45.16 US$451,553
2020-05-07 2020-05-05 PlS Planned sale
Valentine Karen

See Remarks
4,744 -100.0%
40.01
US$189,817 		4,744 -100.0% 40.01 US$189,817
2020-05-07 2020-05-05 PlS Planned sale
2.4
GOLDSMITH MARK A
3,145 -2.2%
40.01
US$125,824 		3,145 -2.2% 40.01 US$125,824
2020-04-29 2020-04-27 PlS Planned sale
Valentine Karen

See Remarks
400 -100.0%
40.13
US$16,052 		400 -100.0% 40.13 US$16,052
2020-04-29 2020-04-27 PlS Planned sale
2.4
GOLDSMITH MARK A
400 -0.3%
40.12
US$16,049 		400 -0.3% 40.12 US$16,049
2020-04-22 2020-04-20 PlS Planned sale
Valentine Karen

See Remarks
789 -100.0%
33.65
US$26,550 		789 -100.0% 33.65 US$26,550
2020-04-20 2020-04-17 PlS Planned sale
Valentine Karen

See Remarks
2,300 -100.0%
35.19
US$80,939 		2,300 -100.0% 35.19 US$80,939
2020-04-20 2020-04-17 PlS Planned sale
Reeve Emma

Chief Financial Officer
760 -100.0%
35.29
US$26,820 		760 -100.0% 35.29 US$26,820
2020-04-20 2020-04-16 PlS Planned sale
Valentine Karen

See Remarks
1,043 -100.0%
34.09
US$35,552 		1,043 -100.0% 34.09 US$35,552
2020-04-20 2020-04-16 PlS Planned sale
Valentine Karen

See Remarks
1,955 -65.2%
33.29
US$65,085 		1,955 -65.2% 33.29 US$65,085
2020-04-16 2020-04-14 PlS Planned sale
Reeve Emma

Chief Financial Officer
1,225 -100.0%
35.20
US$43,123 		1,225 -100.0% 35.20 US$43,123
2020-04-13 2020-04-09 PlS Planned sale
Reeve Emma

Chief Financial Officer
589 -100.0%
35.02
US$20,626 		589 -100.0% 35.02 US$20,626
2020-04-13 2020-04-09 PlS Planned sale
Reeve Emma

Chief Financial Officer
111 -100.0%
35.02
US$3,887 		111 -100.0% 35.02 US$3,887
2020-04-13 2020-04-09 PlS Planned sale
Valentine Karen

See Remarks
635 -100.0%
35.02
US$22,236 		635 -100.0% 35.02 US$22,236
2020-03-23 2020-03-20 B Purchase
3.9
COLUMN GROUP L P

General Partner

Large shareholder
5,539 +0.1%
23.15
US$128,228 		5,539 +0.1% 23.15 US$128,228
2020-03-23 2020-03-20 B Purchase
3.9
COLUMN GROUP L P

General Partner

Large shareholder
5,539 +0.1%
23.15
US$128,228 		5,539 +0.1% 23.15 US$128,228
2020-03-23 2020-03-19 B Purchase
3.9
COLUMN GROUP L P

General Partner

Large shareholder
36,135 +0.6%
22.38
US$808,701 		36,135 +0.6% 22.38 US$808,701
2020-03-23 2020-03-19 B Purchase
3.9
COLUMN GROUP L P

General Partner

Large shareholder
36,135 +0.6%
22.38
US$808,701 		36,135 +0.6% 22.38 US$808,701
2020-03-11 2020-03-09 PlS Planned sale
Valentine Karen

See Remarks
130 -100.0%
32.92
US$4,279 		130 -100.0% 32.92 US$4,279
2020-03-11 2020-03-09 PlS Planned sale
Valentine Karen

See Remarks
335 -72.0%
32.08
US$10,746 		335 -72.0% 32.08 US$10,746
2020-03-11 2020-03-09 PlS Planned sale
Valentine Karen

See Remarks
152 -24.6%
31.17
US$4,738 		152 -24.6% 31.17 US$4,738
2020-02-14 2020-02-13 PlS Planned sale
Reeve Emma

Chief Financial Officer
5,521 -100.0%
35.06
US$193,539 		5,521 -100.0% 35.06 US$193,539
2020-02-14 2020-02-13 PlS Planned sale
Valentine Karen

See Remarks
4,473 -100.0%
35.07
US$156,859 		4,473 -100.0% 35.07 US$156,859
2020-02-14 2020-02-12 PlS Planned sale
Reeve Emma

Chief Financial Officer
1,103 -100.0%
35.02
US$38,624 		1,103 -100.0% 35.02 US$38,624
2020-02-14 2020-02-12 PlS Planned sale
Valentine Karen

See Remarks
1,500 -100.0%
35.02
US$52,527 		1,500 -100.0% 35.02 US$52,527
2020-02-12 2020-02-11 S Sale
Valentine Karen

See Remarks
8,550 -100.0%
35.03
US$299,506 		8,550 -100.0% 35.03 US$299,506
2020-02-12 2020-02-11 S Sale
Reeve Emma

Chief Financial Officer
1,430 -100.0%
35.04
US$50,107 		1,430 -100.0% 35.04 US$50,107
2020-02-12 2020-02-11 S Sale
Reeve Emma

Chief Financial Officer
7,212 -100.0%
35.04
US$252,708 		7,212 -100.0% 35.04 US$252,708
2020-02-12 2020-02-10 S Sale
Valentine Karen

See Remarks
14,096 -100.0%
33.51
US$472,357 		14,096 -100.0% 33.51 US$472,357
2020-02-12 2020-02-10 S Sale
Reeve Emma

Chief Financial Officer
200 -100.0%
35.00
US$7,000 		200 -100.0% 35.00 US$7,000
2019-12-16 2019-12-13 B Purchase Venrock Healthcare Capital Partners III, L.P. Large shareholder
400,000 +11.1%
34.50
US$13,800,000 		400,000 +11.1% 34.50 US$13,800,000
2019-12-16 2019-12-13 B Purchase EVNIN ANTHONY B Non-Executive Director
400,000 +7.5%
34.50
US$13,800,000 		400,000 +7.5% 34.50 US$13,800,000
2019-11-08 2019-11-06 PlS Planned sale Reeve Emma

Chief Financial Officer
726 -100.0%
30.84
US$22,390 		726 -100.0% 30.84 US$22,390
2019-11-08 2019-11-06 PlS Planned sale Reeve Emma

Chief Financial Officer
15,740 -95.6%
29.75
US$468,260 		15,740 -95.6% 29.75 US$468,260
2019-11-08 2019-11-06 PlS Planned sale Reeve Emma

Chief Financial Officer
11,976 -42.1%
20.01
US$239,631 		11,976 -42.1% 20.01 US$239,631
2019-11-08 2019-11-06 PlS Planned sale Reeve Emma

Chief Financial Officer
6,188 -17.9%
19.20
US$118,839 		6,188 -17.9% 19.20 US$118,839
2019-11-08 2019-11-06 PlS Planned sale Reeve Emma

Chief Financial Officer
24,264 -41.2%
18.40
US$446,518 		24,264 -41.2% 18.40 US$446,518
2019-11-08 2019-11-06 PlS Planned sale Reeve Emma

Chief Financial Officer
4,158 -6.6%
17.59
US$73,158 		4,158 -6.6% 17.59 US$73,158
2019-11-08 2019-11-06 PlS Planned sale Reeve Emma

Chief Financial Officer
2,574 -3.9%
16.31
US$41,979 		2,574 -3.9% 16.31 US$41,979
2019-11-08 2019-11-06 PlS Planned sale Raythatha Jigar

See Remarks
350 -2.3%
36.01
US$12,602 		350 -2.3% 36.01 US$12,602
2019-11-08 2019-11-06 PlS Planned sale Raythatha Jigar

See Remarks
20,200 -56.9%
35.23
US$711,579 		20,200 -56.9% 35.23 US$711,579
2019-11-08 2019-11-06 PlS Planned sale Raythatha Jigar

See Remarks
12,095 -25.4%
31.32
US$378,795 		12,095 -25.4% 31.32 US$378,795
2019-11-08 2019-11-06 PlS Planned sale Raythatha Jigar

See Remarks
29,005 -37.9%
30.19
US$875,528 		29,005 -37.9% 30.19 US$875,528
2019-11-08 2019-11-06 PlS Planned sale Raythatha Jigar

See Remarks
20,550 -21.2%
25.06
US$514,952 		20,550 -21.2% 25.06 US$514,952
2019-11-08 2019-11-06 PlS Planned sale Raythatha Jigar

See Remarks
3,170 -3.2%
21.20
US$67,198 		3,170 -3.2% 21.20 US$67,198
2019-11-08 2019-11-06 PlS Planned sale Raythatha Jigar

See Remarks
17,380 -14.8%
20.18
US$350,727 		17,380 -14.8% 20.18 US$350,727
2019-11-08 2019-11-06 PlS Planned sale Audia James E
7,500 -16.1%
19.11
US$143,356 		7,500 -16.1% 19.11 US$143,356
2019-11-08 2019-11-06 PlS Planned sale Audia James E
10,500 -18.4%
18.58
US$195,076 		10,500 -18.4% 18.58 US$195,076
2019-11-08 2019-11-06 PlS Planned sale Audia James E
4,500 -7.3%
17.55
US$78,978 		4,500 -7.3% 17.55 US$78,978
2019-11-08 2019-11-06 PlS Planned sale Senderowicz Adrian

Chief Medical Officer
5,451 -25.5%
35.11
US$191,394 		5,451 -25.5% 35.11 US$191,394
Explore more

More insider trading research around Constellation Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America